CRS Homepage

2006 CRS Annual Mtg

2007 CRS Annual Mtg

2008 CRS Annual Mtg


login/signup

Adobe PDF file Adobe PDF file

 Microsoft Powerpoint file Microsoft Powerpoint

Microsoft Document/Template Microsoft Document

Coming Soon! Coming Soon!


download Adobe Acrobat Reader
35th Annual Meeting and Exposition of the Controlled Release Society

Soapbox Sessions

Emerging Drug Delivery Biotech Companies

Sunday, July 13
Generously Co-sponsored by Molecular Profiles Ltd.

Chairs: Philippe Dor, MacuSight, Inc., U.S.A., and Eyal Ron, Madash LLC, U.S.A.

Identify new ideas and potential collaborations in these fast-paced presentations, where technology-driven emerging and established businesses present their research, products and services.

11:30 – Introduction – Claire Madden-Smith, Molecular Profiles Ltd., U.K.
11:35 – Welcome – Philippe J.M. Dor, MacuSight, Inc., U.S.A., and Eyal S. Ron, MADASH, LLC, U.S.A.

Session 1

Chair: Philippe J.M. Dor, MacuSight, Inc., U.S.A.

  • 11:40 – Optimising Efficacy Through Chronotherapy
    Martin Whitaker, Diurnal Limited
  • 11:45 – Thiomers
    Andreas Bernkop-Schnurch, ThioMatrix GmbH
  • 11:50 – GMP Manufacturing of Liposomes with Polymun’s Technology
    Andreas Wagner, Polymun Scientific GmbH
  • 11:55 – Pioneering Molecular Methods for Improving Oral Bioavailability
    David Goldman, MedCrystalForms, LLC
  • 12:00 - Strategies for Rapid Development of Phase I Pharmaceutical Formulations
    Elizabeth Hickman, Pharmatek Laboratories, Inc.
  • 12:05 - Nanomi - The Art of Microsphere Uniformity
    Henrik Luessen, Tytonis BV representing Nanomi BV
  • 12:10 – Nanoparticular Formulations of Candesartan Cilexetil: LBL-Technology® for Enhancement of Oral BAV
    Joerg Mayer, Capsulution NanoScience AG
  • 12:15-12:30 – BREAK

Session 2

Chair: Eyal S. Ron, MADASH, LLC, U.S.A.

  • 12:30 – The Glide Solid Dose Injector
    Shohre Nabahi, Glide Pharma
  • 12:35 - Microcrystalline Starch: A New Excipient for Preparation of Pharmaceutical Pellets
    Paul Foreman, National Adhesives Division of National Starch & Chemical Co.
  • 12:40 – NanoSolve – Solubilizing System for Lipophilic Actives
    Bruce Baretz, Lipoid GmbH
  • 12:45 – Protection and Controlled Release Using Ceramic Particles
    Chris Barbe, CeramiSphere
  • 12:50 – Disposable Device for Oral Slow Release of Medications
    Harry S. Katz, Novelty Devices LLC, Medical Devices Division
  • 12:55 – RTS SolidPrep High Speed Sample Preparation Automation for Solid Dose Pharmaceutical Analysis
    Mark Fish, RTS Life Science
  • 13:00 - Wrap Matrix - Oral Controlled Drug Delivery System
    Nitin Dharmadhikari, Sun Pharma Advanced Research Company Ltd
  • 13:05-13:20 – BREAK

Session 3

Chair: Philippe J.M. Dor, MacuSight, Inc., U.S.A.

  • 13:20 - The Use of Innovative Monitoring Tools During Drying Processes for High Potent Drug Formulations
    Michael Wiggenhorn, Coriolis PharmaService
  • 13:25 - CriticalMix™ Solvent Free Encapsulation Technology
    Andy Lewis, Critical Pharmaceuticals
  • 13:30 – Spray Drying in Laboratory Scale – Mini Spray Dryer B-290
    Cordin Arpagaus, Büchi Labortechnik AG
  • 13:35 – Innovation in Knowledge Management
    Tugrul Karali, PharmaCircle
  • 13:40 - Primera Analytical Solutions
    David Jones, Primera Analytical Solutions Corp.
  • 13:45 – Bionex - Unlocking Biopharmaceutical Science Potential
    Hock S. Tan, Bionex Pharmaceuticals LLC
  • 13:50 - Magnetic Resonance Imager with Integrated USP-4 Tablet Dissolution System
    Ian Nicholson, Oxford Instruments
  • 13:55-14:10 – BREAK

Session 4

Chair: Eyal S. Ron, MADDASH, LLC, U.S.A.

  • 14:10 - Time Dependent Chemical Imaging Solutions for Dynamic Processes
    David Tuschel and Oksana Olkhovyk, ChemImage Corporation
  • 14:15 – Human Drug Absorption Studies for Defining the Modified Release Formulation Roadmap
    Peter Scholes, Pharmaceutical Profiles
  • 14:20 - TIPS: Site Targeted Delivery with Focused Ultrasound
    Ralf Seip, Philips Research, North America
  • 14:25 – Foamix Develops Easy-to-Use, Safe and Effective Dermatological and Gynecological Foams
    Dov Tamarkin, Foamix Ltd.
  • 14:30 – Beyond Our Website Content and Your Knowledge About Implemented Market Products
    Michael Horstmann, LTS Lohmann Therapie-Systeme AG
  • 14:35 - Novosis - Innovation in Transdermal Drug Delivery
    Thomas Beckert, Novosis
  • 14:40 - State-of-the-art IVIV Correlation - Let Go of Your Old Ideas
    Walter Woltosz, Simulations Plus, Inc.
  • 14:40-14:55 - BREAK